STOCK TITAN

Alimera Sciences to Participate in Upcoming January 2022 Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alimera Sciences (Nasdaq: ALIM) has announced that Rick Eiswirth, President and CEO, will participate in two significant investor conferences in January 2022. He will present at the H.C. Wainwright BioConnect 2022 Virtual Conference, with a pre-recorded session available from January 10 to January 13, 2022. Additionally, he will host one-on-one meetings at the Bio One-on-One Partnering @ JPM event, scheduled for January 10-14, 2022. Alimera focuses on enhancing retinal health and vision longevity for patients and partners.

Positive
  • None.
Negative
  • None.

ATLANTA, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will participate in two investor conference events in January.

Mr. Eiswirth will be presenting at the H.C. Wainwright BioConnect 2022 Virtual Conference. The pre-recorded presentation will be accessible to H.C. Wainwright registered attendees beginning at 7:00 AM ET on Monday, January 10, 2022 - January 13, 2022.

Additionally, Mr. Eiswirth will be hosting one-on-one meetings with registered attendees at Bio One-on-One Partnering @ JPM, January 10, 2022 – January 14, 2022.

About Alimera Sciences, Inc.

Alimera Sciences a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.

For press inquiries:
Jules Abraham
for Alimera Sciences
917-885-7378
julesa@coreir.com
For investor inquiries:
Scott Gordon
for Alimera Sciences
scottg@coreir.com

FAQ

What investor conferences is Alimera Sciences attending in January 2022?

Alimera Sciences will participate in the H.C. Wainwright BioConnect 2022 Virtual Conference and the Bio One-on-One Partnering @ JPM event.

When will Rick Eiswirth's presentation be available for the H.C. Wainwright conference?

Rick Eiswirth's pre-recorded presentation will be accessible from January 10 to January 13, 2022.

What is the purpose of Alimera Sciences' participation in these events?

Alimera Sciences aims to connect with investors and discuss its focus on retinal health and vision longevity.

What is Alimera Sciences' mission?

Alimera Sciences is dedicated to being invaluable to patients, physicians, and partners concerned with retinal health.

How can I learn more about Alimera Sciences?

For more information about Alimera Sciences, visit their website at www.alimerasciences.com.

Alimera Sciences, Inc.

NASDAQ:ALIM

ALIM Rankings

ALIM Latest News

ALIM Stock Data

301.29M
54.38M
5.35%
86.54%
1.06%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
ALPHARETTA